HIGHLIGHTS
- who: Report et al. from the Laboratory parameters have published the research work: Review began 03/30/2022 Review ended 04/16/2022 Published 04/19/2022 u00a9 Copyright, in the Journal: (JOURNAL) of April/19,/2022
- what: Neuroendocrine prostate cancer can arise de novo or as the treatment-associated transformation of an established adenocarcinoma.
SUMMARY
Treatment-emergent transformed neuroendocrine prostate cancer (NEPC) is a highly aggressive type of prostate cancer that may arise from typical adenocarcinoma of the prostate, which is associated with rapidly progressive disease involving visceral sites and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.